ALKERMES | Ventes



Sales Changement Date
AbbVie USD 15.42B 2.08B 2025-06
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
ALKERMES USD 390.7M 84.2M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Eli Lilly USD 15.56B 2.83B 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
J&J USD 23.74B 1.85B 2025-06
Malin Corporation EUR 19.2M 2.6M 2020-12
Merck USD 15.81B 280M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
Otsuka Holdings JPY 597.93B 15.09B 2025-06
Pfizer USD 14.7B 980M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


ALKERMES Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.